Nachrichten zur Kenvue Inc. Aktie

Kenvue Inc stock hits 52-week low at 16.06 USD…

After a bruising session on Monday, Kenvue Inc (NYSE:KVUE) shares staged a 6% rebound in premarket trade on Tuesday, clawing back…

Kenvue Inc (NYSE:KVUE) shares dropped 4% at the open on Monday, erasing about $1.4 billion in market value, after a…

Kenvue Inc. (NYSE:KVUE) is a consumer health company that offers well-known brands in categories like pain management, skin and beauty,…

Kenvue Inc (NYSE:KVUE) reported second quarter sales below Wall Street expectations, while also downwardly revising its full-year profit forecast. The...…

Kenvue Inc (NYSE:KVUE) is again at the center of takeover speculation as the August expiration of its post–spin-off tax agreement with…

Kenvue Inc (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson (NYSE:JNJ) in 2023, is considering selling a…

Consumer brands firm Kenvue Inc (NYSE:KVUE) traded on the front foot in Thursday’s early deals, as its second quarter beat…

…

…

Kenvue Inc (NYSE:KVUE), the maker of Listerine, Tylenol, Aveeno and Band-Aid, reported slightly lower sales than expected but earnings were just…

Kenvue Inc (NYSE:KVUE) shares moved more than 6% higher on reports activist investor Starboard Value has taken a stake in…

Der aktivistische Investor Starboard Value hat laut mit der Angelegenheit vertrauten Personen eine beträchtliche Beteiligung an Kenvue Inc. (NYSE:…

…

…

Shares in Kenvue Inc (NYSE:KVUE) were up 9% in pre-market trading after the company exceeded Wall Streets expectations for second-quarter profit and...…

…

Kenvue Inc (NYSE:KVUE) shares moved higher after the Tylenol-maker posted better-than-expected first quarter earnings on Tuesday. Shares of the Johnson…

…

Neutrogena is permanently closing its Los Angeles office as parent Kenvue Inc. consolidates operations to New Jersey.…